Research article · 30 Jul 2026
Research articlePublished 28 Dec 2022
Efficacy, Tolerability and Cosmetic Acceptability of a Growth Factors, Caffeine, Taurine and a Chelating Complex-Based Gel in Subjects with Hair Loss Alone or In Combination with Drugs Treatments: A Real Life, Multicentre, Assessor-Blinded, 6-Month T
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: We evaluated efficacy, tolerability, and cosmetic acceptability of a gel containing growth factors, taurine, caffeine and iron chelating complex (GFmgel) in subjects with hair loss (AGA/FAGA, TE) in a real-life condition. Materials and methods: 471 subjects (273 women) with hair loss conditions (AGA/FAGA: n=269; or chronic TE, n=202) were enrolled. Eligible subjects could be naïve (no specific hair loss treatments) or treated with anti-hair loss drugs since at least 6 months. GFmgel (12.5 ml per application) should be applied on the scalp once weekly. The primary outcome was the Global Assessment Score (GAS) using a 7-point scale in comparison with baseline condition after 6 months of therapy. At baseline a global picture of the scalp was performed to be used for the GAS evaluation. A total of 229 subjects were treated with GFmgel alone (G1), 136 with GFmgel and topical minoxidil (G2); 34 subjects with GFmgel and oral finasteride (1 mg/die) (G3) and finally 69 subjects with GFmgel and multitherapy (drug and/or adjuvants) (G4). Results: In the population as a whole GAS at month 6 significantly increased in all groups in comparison with baseline: G1: +1.6 ± 1; G2: +1.8 ± 1; G3: +2 ± 1 and G4: +2.1 ± 1. GAS scores of G4, G3 and G2 were significantly higher (p=0.02) in comparison with G1. In AGA/FAGA subjects the GAS scores were 1.2 ± 1 in G1, 1.7 ± 1 in G2, 2.2± 1 in G3 and 1.7 ± 1 in G4. GAS scores of G4, G3 and G2 groups were significantly higher (p=0.001) in comparison with G1. In TE subjects the GAS scores were: 1.9 ± 1 in G1, 1.9 ± 1 in G2 and 2.0 ± 0.8 in G4. No statistical differences between G1, G2 and G4 groups were observed for the GAS scores. The gel was very well tolerated. Cosmetic acceptability was judged good or very good by 75% of the subjects. Conclusion: This gel has shown to be very effective as therapeutic strategy in subjects with hair loss (AGA/FAGA) used alone or in combination with drugs treatment. In subjects with chronic TE the use of this gel as monotherapy has shown an efficacy comparable to combination therapies.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Dermatology Research.
Commentary · 30 Jul 2026
Breaking the Stigma Around Psoriasis: A Broader View of Chronic Skin Disease
Perspective · 28 Jul 2026
Acne as More Than a Cosmetic Concern: A Personal and Medical Perspective
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Alfredo Caruso”
- BylineArticles whose byline prints “Angelo Massimiliano D'Erme”
- BylineArticles whose byline prints “Anna Bordin”
- BylineArticles whose byline prints “Antonella Balducci”
- BylineArticles whose byline prints “Antonello Bonifati”
- BylineArticles whose byline prints “Antonina Agolzer”
- BylineArticles whose byline prints “Antonio Carpentieri”
- BylineArticles whose byline prints “Antonio Del Sorbo”
